 |
|
Using Corticosteroids in Intensive Care
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
We read the study by Britt et al1 on the use of corticosteroids in the intensive care unit and the accompanying critique with much interest. The article has a number of serious methodological issues that render the results of the study difficult to interpret. Most importantly, the authors did not report the dose (in hydrocortisone equivalents) of corticosteroid the patients received, nor did they stratify the patients into "high" and "low" dose groups.2-5 This is critically important because the "mega-industrial" dose of corticosteroid used for acute spinal cord injuries (equivalent to approximately 50 000 mg of hydrocortisone) is potently immunosuppressive and myolytic and associated with an increased risk of secondary infections and myopathy.4, 6 Conversely, the low dosage of corticosteroid (200-300 mg of hydrocortisone per day) used to restore the balance between the dysregulated proinflammatory and anti-inflammatory response in patients with septic shock and acute respiratory distress syndrome does not cause immune . . . [Full Text of this Article]
AUTHOR INFORMATION
Paul E. Marik, MD;
Djillali Annane, MD;
Charles L. Sprung, MD;
Wiebke Arlt, MD;
Didier Keh, MD for the International Task Force on the Diagnoses and Management of Adrenal Insufficiency in the Critically Ill
RELATED ARTICLES
Using Corticosteroids in Intensive Care—Reply
Rebecca C. Britt
Arch Surg. 2006;141(9):947.
EXTRACT
| FULL TEXT
Corticosteroid Use in the Intensive Care Unit: At What Cost?
Rebecca C. Britt, Alicia Devine, Karen C. Swallen, Leonard J. Weireter, Jay N. Collins, Frederic J. Cole, and L. D. Britt
Arch Surg. 2006;141(2):145-149.
ABSTRACT
| FULL TEXT
|
